Now loading.
Please wait.

Menu

+91-11-23736906

htain-dhr@nic.in

Multicentric Studies

HomeMulticentric Studies
HomeMulticentric Studies

Multi-Centric Studies


Sr. No. Multi-Centric Studies
1 National Costing Study of Health care in 16 States to support Ayushmann Bharat-PMJAY Health Benefit Package Revision.
2 Cost effectiveness of the PM-JanAushadhi Program
3 Cost effectiveness threshold for India.
4 Price Regulation & Value-Based Pricing for Anti-Cancer Drugs: Implications for Patients, Industry, Insurer and Regulator.
a) Assessment of economic burden and Quality of Life among cancer patients in India: National Cancer Database for Costs and Quality of Life (CaDCQoL)
b) Cost-effectiveness of Ribociclib and Palbociclib in the second-line treatment of Hormone receptor-positive, HER2 negative metastatic breast cancer among post-menopausal women
c) Cost-Effectiveness Analysis of Bevacizumab Plus Chemotherapy Versus Chemotherapy Alone for the Treatment of Advanced and Metastatic Cervical Cancer in India
d) Price and trade margin regulation of Anti-Cancer medicines
5 Establishing DHR-ICMR Advanced Molecular Oncology Diagnostic Services (DIAMOnDS)
All for Joomla All for Webmasters